Local jabs yet to join Covid fight
2
Firms eye regional hub push
published : 6 Jun 2021 at 06:22
2 Medical workers take nasal swabs from people who arrive for a Covid-19 test at the Bansomdejchaopraya Rajabhat Institute in Bangkok.
Thais are expected to get locally developed Covid-19 vaccines as a third booster jab next year.
None of the three Thai-made vaccines have yet passed clinical trials. So, they cannot be used to tackle the current wave of Covid-19 outbreak or ease the vaccine shortage problem.
However, researchers behind the domestic vaccine efforts insist their vaccine research and development work can still help long-term efforts to stop Covid-19 and enhance the country s ability to fight such diseases in the future.
The inoculation challenge The inoculation challenge
The government is being scrutinised for buying a Chinese vaccine with low efficacy rates and ties to CP Group, while the most of the population is being supplied by a firm with little experience with vaccines
published : 18 Jan 2021 at 04:30
4 The cabinet approved plans to procure several million doses of Covid-19 vaccines during 2021. Apichart Jinakul
The country is eagerly awaiting the administration process in February of CoronaVac, a Covid-19 vaccine developed by a Chinese biopharmaceutical company, which recently received a hefty investment from a Thai conglomerate.
As the race to develop effective Covid-19 vaccines heats up among several pharmaceutical companies, in an effort to counter the surge of infections worldwide, the Thai government is also in a race against time to secure much-needed vaccines, hoping inoculations will provide a beaco